79 results
8-K
EX-99.1
ODYY
Odyssey Health, Inc.
13 Dec 23
Regulation FD Disclosure
5:10pm
of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only
8-K
EX-99.1
f3chi
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
8h4ss
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-2.1
mapzm g4miidr7hgap
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-10.1
lbpxs zvqdn5i
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-99.1
w4d sxdyt0oek1tynr8
25 Nov 22
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
8:30am
8-K
EX-10.1
tr3cza
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
kxj6 unfj7dt
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-10.2
35nq1019oy3ab81k0kq
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-99.1
h51thduei
4 Nov 22
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
4:16pm
8-K
EX-99.1
dfejwvsneuc36xcv
1 Nov 22
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
8:45am
8-K
EX-99.1
ydtxu6c
30 Sep 22
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
5:51pm
8-K
EX-99.1
rm1cypyc
30 Sep 22
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
5:20pm
8-K
EX-99.1
xo7q4m6xq nt
18 Aug 22
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial
4:02pm